tiprankstipranks
pc:pepro

PeproMene Bio Inc

15375 Barranca Pkwy Suite A211 Irvine, California 92618, us
https://pepromenebio.com/
PeproMene Bio Inc is a biotechnology company focused on developing targeted immunotherapies for cancer and autoimmune diseases. The company is advancing its BAFF-R CAR T cell therapy, PMB-CT01, specifically for patients with relapsed or refractory follicular lymphoma. PeproMene Bio aims to address unmet medical needs in the treatment of B-cell Non-Hodgkin Lymphoma through innovative cellular therapies.

Leadership & Board

Current Number of Employees11
Current LinkedIn Followers615

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$11M
Total Amount Raised$11M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$11M
Latest Funding Amount$11M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Employee Trend

PeproMene Bio Inc had 11 employees as of April 6, 2026. The number of employees increased by 1 (10.00%) week-over-week.
11Latest Employee Count
1(10.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

PeproMene Bio Inc had 615 followers as of April 6, 2026. The number of followers increased by 0 (0.00%) week-over-week.
615Latest Followers Count
0(0.00%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Aug 14, 2025
Investment
$11.00M

Investors

Investor Name
Funding Round

Related News and Analysis